RLMD Earnings

Quarterly EPS
$-0.72
Q3 2024
$-0.62
Q4 2024
$-0.58
Q1 2025
$-0.30
Q2 2025
$-0.30
Q3 2025
$-0.33
Q4 2025
$-0.22
Q1 2026
$-0.11
Q2 2026
Latest RevenueN/A
Latest Net Income-12914185
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.110-12914185+63.3%
Q1 2026-$0.220-19051956+62.1%
Q4 2025-$0.330-19867760+46.8%
Q3 2025-$0.300-10091496+58.3%
Q2 2025-$0.300-9866442+49.2%
Q1 2025-$0.580-17559465+19.4%
Q4 2024-$0.620-18657136+26.2%
Q3 2024-$0.720-21725970+1.4%
Q2 2024-$0.590-17768122
Q1 2024-$0.720-21828126
Q4 2023-$0.840-25165158
Q3 2023-$0.730-22002058
Relmada Therapeutics (RLMD) — Earnings